FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Video: How to treat kidney disease?

2.

Daily physical activity, even at light intensities, linked to lower cancer risk

3.

Updates from the 2022 WHO classification of kidney epithelial tumors

4.

A new blood test greatly increases the ability to detect cancer.

5.

MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot